The generation of induced pluripotent stem cells (iPSCs) free of integrated transgenes is a critical step toward their safe clinical application in regenerative medicine and drug development.
The efficient generation of mature, functional neurons from human induced pluripotent stem cells (iPSCs) is critical for advancing disease modeling and drug screening.
This article provides a comprehensive guide for researchers and drug development professionals on the latest strategies to enhance the efficiency and safety of induced pluripotent stem cell (iPSC) generation.
This article provides a comprehensive guide for researchers and drug development professionals on managing genomic instability in induced pluripotent stem cells (iPSCs) during extended culture.
Spontaneous differentiation remains a significant challenge in induced pluripotent stem cell (iPSC) culture, compromising experimental reproducibility and the efficacy of cell therapies.
This article provides a comprehensive comparison of Matrigel and laminin coatings for induced pluripotent stem cell (iPSC) culture, tailored for researchers and drug development professionals.
Sendai virus (SeV) vector technology has emerged as a leading method for generating induced pluripotent stem cells (iPSCs) without genomic integration, a critical safety consideration for clinical applications.
This article provides a comprehensive overview of the transformative role of induced pluripotent stem cell (iPSC)-derived motor neurons in modeling Amyotrophic Lateral Sclerosis (ALS).
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have revolutionized cardiac arrhythmia research by providing a patient-specific platform for disease modeling, drug screening, and safety pharmacology.
This article provides a comprehensive and up-to-date analysis of the protocols for directly reprogramming somatic cells into induced pluripotent stem cells (iPSCs).